fashion -WSS

fashion

author：focus 2025-09-28 08:53:18 - browse：93

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： Georgia court denies Trump's request to quash DA's 2020 election probe

focus

WSS

How a scoliosis diagnosis changed the life of one young dancer

Who gets to use the title 'doctor'?

Eli Lilly to acquire Versanis in heated race for weight loss drugs

AdventHealth escalates lawsuit against insurance vendor Multiplan

Morgan Health, with ambitious aims, wants you to know it’s still here

Antibiotic resistance and the global rise in human conflict

focus

fashion

focus

Apple is now the first public company to be valued at $3 trillion

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

George Santos makes 1st court appearance after pleading not guilty to 13 counts

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

New weight loss drugs work. But how can they best be used?

Hepatitis C has a cure — but many Americans still lack access to it

A single drug, study failures leave Anavex with nothing but cash

Malaria cases in Florida and Texas: Here’s what you need to know

AdventHealth escalates lawsuit against insurance vendor Multiplan

entertainment

New weight loss drugs work. But how can they best be used?

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Involuntary treatment for addiction doesn't work

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Feng Zhang, Grail founder join forces on new gene editing startup

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

focus

Wikipedia

focus

explore